National HIV Testing Day has raised awareness and confront stereotypes about HIV. Learn about HIV testing options and ...

June 27 is National HIV Testing Day, a time to encourage people to learn their status. Early HIV diagnosis is critical, ...

HIV/Aids breakthrough not a 'cure', popular social media posts misrepresent the factsIN SHORT: While promising, a recent breakthrough in HIV research is not a "cure" or a "vaccine", as several posts ...

Drawing from 19 studies across sub-Saharan Africa and select global contexts, the review finds that RHIS remain largely ...

The Trump administration's plan to cut funding for HIV vaccine research comes at a time when the field is making substantial ...

The Food and Drug Administration approved the preventative use of lenacapavir, made by Gilead Sciences, on Wednesday. Experts ...

Yeztugo, approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year, and people have to be HIV-negative to get it.

Gene therapy may be a crucial tool to put HIV to sleep permanently, providing a lasting and durable treatment against the v ...

In clinical trials, researchers found Yeztugo to be highly effective as a twice-yearly form of pre-exposure prophylaxis.

The Division of Public Health and Community Services is offering Human Immunodeficiency Virus testing in Nashua and Milford ...

WASHINGTON — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global ...

The FDA approved lenacapavir (Yeztugo) as pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 in at ...